ReleaseBytes
snowflake Snowflake Blog ·

Snowflake Simplifies Data Integration for Life Sciences M&A

blogsnowflakearchitecthealthcare
announcement

This article details how Snowflake's data platform capabilities streamline complex data integration challenges inherent in life sciences mergers, acquisitions, and divestitures. It explains how features like Secure Data Sharing and Data Clean Rooms enable immediate access to critical data, reduce migration timelines, and ensure regulatory compliance and patient privacy. The approach helps life sciences organizations maintain data lineage, protect intellectual property, and ensure operational continuity during these high-stakes transitions. This minimizes the historically time-consuming and expensive nature of traditional M&A data integration.

  • →Enable Immediate Data Access Without Migration
  • →Support Federated Architectures in Regulated Environments
  • →Utilize Data Clean Rooms for Legally Sensitive Periods
  • →Streamline Data Divestitures with Cloning and Granular Security
  • →Understanding Life Sciences M&A Data Integration Challenges
Features (4) ›
  • Enable Immediate Data Access Without Migration

    Snowflake's Secure Data Sharing architecture allows immediate, live access to target company data without physical migration, ETL, or duplication, enabling swift integration for clinical operations, finance, and regulatory affairs teams on Day 1 of a deal.

  • Support Federated Architectures in Regulated Environments

    Snowflake's multi-account architecture enables each entity to maintain its own validated environment and access controls, facilitating integration at the reporting and analytics layer while preserving GxP compliance and consolidated visibility for the parent company.

  • Utilize Data Clean Rooms for Legally Sensitive Periods

    Snowflake Data Clean Rooms allow joint analysis, combined forecasts, and integrated reports during legally mandated data access constraints (e.g., antitrust reviews), ensuring computation in a shared environment without raw data leaving either party's control.

  • Streamline Data Divestitures with Cloning and Granular Security

    Snowflake addresses divestiture complexities through Zero-Copy Cloning, which creates independent data copies for divested entities without duplicating storage costs, and row- and column-level security for surgical data restriction during transition periods.

Notes (1) ›
  • Understanding Life Sciences M&A Data Integration Challenges

    The life sciences industry faces significant data complexity during M&A and divestitures, including ensuring regulatory continuity, protecting patient data privacy, preserving data lineage, managing long data histories, valuing dormant research assets, and securing intellectual property.

Read the original announcement →

https://www.snowflake.com/content/snowflake-site/global/en/blog/ma-data-integration

Related releases